Penumbra Q2 2022 Earnings Report
Key Takeaways
Penumbra, Inc. reported a revenue increase of 13.1% in the second quarter of 2022, reaching $208.3 million. Vascular products and international sales were key growth drivers. The company is maintaining its full-year revenue guidance of $860 million to $875 million.
Total revenue increased to $208.3 million, a 13.1% increase compared to Q2 2021.
Revenue from vascular products grew by 22.7% to $123.5 million.
Revenue from neuro products grew by 1.5% to $84.8 million.
The United States accounted for 68% of total revenue, while international sales represented 32%.
Penumbra
Penumbra
Penumbra Revenue by Geographic Location
Forward Guidance
The Company is maintaining its guidance for 2022 total revenue to be in the range of $860 million to $875 million. Due to foreign currency fluctuations, the Company expects total 2022 reported revenue to be at the lower end of this range, however it expects to maintain growth of 15 – 17% over 2021 revenue on a constant currency basis.
Revenue & Expenses
Visualization of income flow from segment revenue to net income